Brief: Intelgenx Files Provisional U.S. Patent Application For Advanced Oral Film Formulation Improving Cannabinoid Onset Of Action
02/11/2022 12:25
Nov 2 (Reuters) - Intelgenx Technologies Corp IGX.TO :
* INTELGENX FILES PROVISIONAL U.S. PATENT APPLICATION FOR
ADVANCED
ORAL FILM FORMULATION IMPROVING CANNABINOID ONSET OF ACTION
Source text for Eikon: ID:nGNX7RgbZR
Further company coverage: IGX.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA